Next Article in Journal
The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury
Next Article in Special Issue
High Endogenous Accumulation of ω-3 Polyunsaturated Fatty Acids Protect against Ischemia-Reperfusion Renal Injury through AMPK-Mediated Autophagy in Fat-1 Mice
Previous Article in Journal
Effects of Fullerenols on Mouse Brain Microvascular Endothelial Cells
Previous Article in Special Issue
Enriching Diet with n-3 PUFAs to Help Prevent Cardiovascular Diseases in Healthy Adults: Results from Clinical Trials
Review

A Critical Review on the Effect of Docosahexaenoic Acid (DHA) on Cancer Cell Cycle Progression

1
Department of Agricultural Food and Nutritional Science, Faculty of Agricultural, Life and Environmental Sciences, 4-126 Li Ka Shing Center for Health Research Innovation, University of Alberta, Edmonton, AB T6G 2E1, Canada
2
Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2E1, Canada
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2017, 18(8), 1784; https://doi.org/10.3390/ijms18081784
Received: 1 August 2017 / Revised: 14 August 2017 / Accepted: 16 August 2017 / Published: 17 August 2017
(This article belongs to the Special Issue Omega-3 Fatty Acids in Health and Disease: New Knowledge)
Globally, there were 14.1 million new cancer diagnoses and 8.2 million cancer deaths in 2012. For many cancers, conventional therapies are limited in their successes and an improved understanding of disease progression is needed in conjunction with exploration of alternative therapies. The long chain polyunsaturated fatty acid, docosahexaenoic acid (DHA), has been shown to enhance many cellular responses that reduce cancer cell viability and decrease proliferation both in vitro and in vivo. A small number of studies suggest that DHA improves chemotherapy outcomes in cancer patients. It is readily incorporated into cancer cell membranes and, as a result there has been considerable research regarding cell membrane initiated events. For example, DHA has been shown to mediate the induction of apoptosis/reduction of proliferation in vitro and in vivo. However, there is limited research into the effect of DHA on cell cycle regulation in cancer cells and the mechanism(s) by which DHA acts are not fully understood. The purpose of the current review is to provide a critical examination of the literature investigating the ability of DHA to stall progression during different cell cycle phases in cancer cells, as well as the consequences that these changes may have on tumour growth, independently and in conjunction with chemotherapy. View Full-Text
Keywords: cancer; cell cycle; cyclins; docosahexaenoic acid (DHA); G1 phase; G2M phase; omega-3; synergistic; proliferation; arrest; chemotherapy cancer; cell cycle; cyclins; docosahexaenoic acid (DHA); G1 phase; G2M phase; omega-3; synergistic; proliferation; arrest; chemotherapy
Show Figures

Figure 1

MDPI and ACS Style

Newell, M.; Baker, K.; Postovit, L.M.; Field, C.J. A Critical Review on the Effect of Docosahexaenoic Acid (DHA) on Cancer Cell Cycle Progression. Int. J. Mol. Sci. 2017, 18, 1784. https://doi.org/10.3390/ijms18081784

AMA Style

Newell M, Baker K, Postovit LM, Field CJ. A Critical Review on the Effect of Docosahexaenoic Acid (DHA) on Cancer Cell Cycle Progression. International Journal of Molecular Sciences. 2017; 18(8):1784. https://doi.org/10.3390/ijms18081784

Chicago/Turabian Style

Newell, Marnie, Kristi Baker, Lynne M. Postovit, and Catherine J. Field. 2017. "A Critical Review on the Effect of Docosahexaenoic Acid (DHA) on Cancer Cell Cycle Progression" International Journal of Molecular Sciences 18, no. 8: 1784. https://doi.org/10.3390/ijms18081784

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop